← Insider buys
ACAD

Acadia Pharmaceuticals Inc. · Healthcare

Director James M Daly sold $1.3M of Acadia Pharmaceuticals Inc.

Sold$1,342,178
$51.13Price
26,250Shares
−100%Stake

What ACAD did after the filing

Prices for ACAD after this filing aren't in yet.

Traded Mon, May 11. Filed Wed, May 13, 6:00 PM ET, after the close. Not investment advice.